{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:16:00Z","timestamp":1790169360927,"version":"4.1.0"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T00:00:00Z","timestamp":1405555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Fund for Scientific Research Flanders","award":["GOA\/11\/014"],"award-info":[{"award-number":["GOA\/11\/014"]}]},{"name":"Government agency for Innovation by Science and Technology","award":["P7\/16"],"award-info":[{"award-number":["P7\/16"]}]},{"name":"University of Leuven","award":["n\u00b016525"],"award-info":[{"award-number":["n\u00b016525"]}]},{"name":"Belgian Federal Science Policy Office","award":["039CUK"],"award-info":[{"award-number":["039CUK"]}]},{"name":"Belgian Federal Science Policy Office","award":["14-LGCA-181"],"award-info":[{"award-number":["14-LGCA-181"]}]},{"name":"European Community","award":["MDA295317"],"award-info":[{"award-number":["MDA295317"]}]},{"name":"Association Belge contre les Maladies neuro-Musculaires"},{"name":"Association Fran\u00e7aise contre les Myopathies"},{"name":"Belgian ALS Liga"},{"DOI":"10.13039\/100006402","name":"ALS Therapy Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006402","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALS Association"},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"name":"E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.expneurol.2014.07.001","type":"journal-article","created":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T09:02:56Z","timestamp":1405069376000},"page":"138-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"PB","title":["Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS)"],"prefix":"10.1016","volume":"262","author":[{"given":"Lindsay","family":"Poppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ru\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Robberecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludo","family":"Van Den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2014.07.001_bb0005","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/104303402753812458","article-title":"Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy","volume":"13","author":"Acsadi","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/WNL.16.5.475","article-title":"Ultrastructure of atrophic muscle in amyotrophic lateral sclerosis","volume":"16","author":"Afifi","year":"1966","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00401-012-1022-4","article-title":"The genetics and neuropathology of amyotrophic lateral sclerosis","volume":"124","author":"Al-Chalabi","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0020","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.57.7.1282","article-title":"Immune reactivity in a mouse model of familial ALS correlates with disease progression","volume":"57","author":"Alexianu","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-013-1149-y","article-title":"Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons","volume":"126","author":"Almeida","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00401-012-0984-6","article-title":"Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain","volume":"124","author":"Aoki","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0035","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/ng.2434","article-title":"Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models","volume":"44","author":"Armakola","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0040","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","article-title":"Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS","volume":"77","author":"Ash","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature02544","article-title":"VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model","volume":"429","author":"Azzouz","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.tins.2010.09.001","article-title":"Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications","volume":"33","author":"Banerjee","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0055","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1073\/pnas.0607423103","article-title":"Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis","volume":"103","author":"Beers","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0060","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0807419105","article-title":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS","volume":"105","author":"Beers","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0065","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/brain\/awr074","article-title":"Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis","volume":"134","author":"Beers","year":"2011","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0075","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0070","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s004150200071","article-title":"A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis","volume":"249","author":"Bensimon","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0080","doi-asserted-by":"crossref","first-page":"e61177","DOI":"10.1371\/journal.pone.0061177","article-title":"Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis","volume":"8","author":"Berry","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0085","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.neurobiolaging.2011.06.002","article-title":"Dietary restriction but not rapamycin extends disease onset and survival of the H46R\/H48Q mouse model of ALS","volume":"33","author":"Bhattacharya","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0090","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1073\/pnas.1202922109","article-title":"Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability","volume":"109","author":"Bilican","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0095","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/humu.22329","article-title":"A rare motor neuron deleterious missense mutation in the DPYSL3 (CRMP4) gene is associated with ALS","volume":"34","author":"Blasco","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/mus.20609","article-title":"Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases","volume":"34","author":"Bogaert","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0100","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.neurobiolaging.2008.12.007","article-title":"VEGF protects motor neurons against excitotoxicity by upregulation of GluR2","volume":"31","author":"Bogaert","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0110","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boillee","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.107.123000","article-title":"Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis","volume":"322","author":"Bordet","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.mcn.2013.07.007","article-title":"A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells","volume":"56","author":"Burkhardt","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0125","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/brain\/awr195","article-title":"Motor neuron dysfunction in frontotemporal dementia","volume":"134","author":"Burrell","year":"2011","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/scdb.2001.0290","article-title":"Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders","volume":"13","author":"Carmeliet","year":"2002","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0135","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4161\/auto.25188","article-title":"Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons","volume":"9","author":"Castillo","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0140","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1073\/pnas.0804610105","article-title":"T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","article-title":"Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice","volume":"302","author":"Clement","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/375061a0","article-title":"Defective axonal-transport in a transgenic mouse model of amyotrophic-lateral-sclerosis","volume":"375","author":"Collard","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0160","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.410410212","article-title":"Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis","volume":"41","author":"Cudkowicz","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.20903","article-title":"Trial of celecoxib in amyotrophic lateral sclerosis","volume":"60","author":"Cudkowicz","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0155","first-page":"S36.001","article-title":"STAGE 3 clinical trial of ceftriaxone in subjects with ALS (S36.001)","volume":"80","author":"Cudkowicz","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0170","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S1474-4422(13)70221-7","article-title":"Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial","volume":"12","author":"Cudkowicz","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0180","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cmet.2012.03.019","article-title":"Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS","volume":"15","author":"Da Cruz","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0185","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1093\/hmg\/ddm226","article-title":"Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content","volume":"16","author":"De Vos","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.neuro.31.061307.090711","article-title":"Role of axonal transport in neurodegenerative diseases","volume":"31","author":"De Vos","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0195","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mcn.2006.03.002","article-title":"The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease","volume":"32","author":"De Winter","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0210","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1128\/MCB.01279-10","article-title":"TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor","volume":"31","author":"Dewey","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0215","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nn1885","article-title":"Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model","volume":"10","author":"Di Giorgio","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0220","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0225","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.200407021","article-title":"Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model","volume":"168","author":"Dobrowolny","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0230","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/mt.2010.206","article-title":"AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice","volume":"18","author":"Dodge","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0235","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cell.2011.05.034","article-title":"The human brain in a dish: the promise of iPSC-derived neurons","volume":"145","author":"Dolmetsch","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0240","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuron.2013.10.015","article-title":"RNA toxicity from the ALS\/FTD C9ORF72 expansion is mitigated by antisense intervention","volume":"80","author":"Donnelly","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0245","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1038\/emboj.2010.143","article-title":"ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import","volume":"29","author":"Dormann","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0250","doi-asserted-by":"crossref","first-page":"13248","DOI":"10.1073\/pnas.95.22.13248","article-title":"EphA4 (Sek1) receptor tyrosine kinase is required for the development of the corticospinal tract","volume":"95","author":"Dottori","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0255","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.10374","article-title":"Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS","volume":"52","author":"Drachman","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0260","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/nbdi.2002.0522","article-title":"Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis","volume":"10","author":"Dupuis","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0175","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nm.2396","article-title":"HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot\u2013Marie\u2013Tooth disease","volume":"17","author":"d'Ydewalle","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0265","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/dbio.2002.0695","article-title":"EphA4 constitutes a population-specific guidance cue for motor neurons","volume":"247","author":"Eberhart","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0270","doi-asserted-by":"crossref","first-page":"145ra104","DOI":"10.1126\/scitranslmed.3004052","article-title":"Drug screening for ALS using patient-specific induced pluripotent stem cells","volume":"4","author":"Egawa","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0275","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000080049","article-title":"Neurotrophic factors and amyotrophic lateral sclerosis","volume":"1","author":"Ekestern","year":"2004","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0280","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0285","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archneur.1993.00540010026013","article-title":"Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis","volume":"50","author":"Engelhardt","year":"1993","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0290","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/hmg\/ddt202","article-title":"PGC-1alpha is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis","volume":"22","author":"Eschbach","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0295","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1093\/hmg\/dds205","article-title":"The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth","volume":"21","author":"Fallini","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0300","doi-asserted-by":"crossref","first-page":"23465","DOI":"10.1074\/jbc.M703434200","article-title":"Stabilization of hyperdynamic microtubules is neuroprotective in amyotrophic lateral sclerosis","volume":"282","author":"Fanara","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0310","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/archneurol.2011.250","article-title":"SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"68","author":"Fecto","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0305","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P05.164","article-title":"Autophagy is impaired by UBQLN2 mutations linked to ALS\/FTD","volume":"78","author":"Fecto","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0315","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0320","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nbd.2008.12.003","article-title":"Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS","volume":"33","author":"Franz","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0325","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/srep01016","article-title":"C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes","volume":"2","author":"Fratta","year":"2012","journal-title":"Sci. Reports"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0330","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1523\/JNEUROSCI.20-07-02534.2000","article-title":"Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases","volume":"20","author":"Frey","year":"2000","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0335","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1152\/jn.00500.2012","article-title":"Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability","volume":"109","author":"Fritz","year":"2013","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0340","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/hmg\/dds495","article-title":"Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7","volume":"22","author":"Furrer","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0345","first-page":"190","article-title":"Vitamin E intake and quality of life in amyotrophic lateral sclerosis patients: a follow-up case series study","volume":"27","author":"Galbussera","year":"2006","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0350","doi-asserted-by":"crossref","first-page":"383087","DOI":"10.1155\/2011\/383087","article-title":"Animal models of MS reveal multiple roles of microglia in disease pathogenesis","volume":"2011","author":"Gao","year":"2011","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0355","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-013-1192-8","article-title":"Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD\/ALS","volume":"126","author":"Gendron","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0360","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1476-5381.2010.00725.x","article-title":"High-throughput screening and small animal models, where are we?","volume":"160","author":"Giacomotto","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0365","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1474-4422(11)70261-7","article-title":"A C9orf72 promoter repeat expansion in a Flanders\u2013Belgian cohort with disorders of the frontotemporal lobar degeneration\u2013amyotrophic lateral sclerosis spectrum: a gene identification study","volume":"11","author":"Gijselinck","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0370","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1523\/JNEUROSCI.2981-04.2004","article-title":"Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice","volume":"24","author":"Goldshmit","year":"2004","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0375","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1523\/JNEUROSCI.20-02-00660.2000","article-title":"Restricted expression of G86R Cu\/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration","volume":"20","author":"Gong","year":"2000","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0380","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0385","doi-asserted-by":"crossref","first-page":"10234","DOI":"10.1523\/JNEUROSCI.3494-08.2008","article-title":"Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase","volume":"28","author":"Gowing","year":"2008","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0390","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2010.06683.x","article-title":"Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS","volume":"113","author":"Gros-Louis","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0395","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor-neuron degeneration in mice that express a human Cu, Zn superoxide-dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0400","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nbt.1957","article-title":"Astrocytes from familial and sporadic ALS patients are toxic to motor neurons","volume":"29","author":"Haidet-Phillips","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0405","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#","article-title":"Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS","volume":"23","author":"Hall","year":"1998","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0410","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0415","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/emmm.201201544","article-title":"Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival","volume":"5","author":"Henkel","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0420","first-page":"32","article-title":"Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?","volume":"4","author":"Henriques","year":"2010","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0425","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1101\/gad.1830709","article-title":"XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy","volume":"23","author":"Hetz","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0430","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2202-4-16","article-title":"ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes","volume":"4","author":"Higgins","year":"2003","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0435","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0440","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI59130","article-title":"Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats","volume":"122","author":"Huang","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0445","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/gt.2009.80","article-title":"Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice","volume":"16","author":"Hwang","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0450","doi-asserted-by":"crossref","first-page":"e54511","DOI":"10.1371\/journal.pone.0054511","article-title":"dnc-1\/dynactin 1 knockdown disrupts transport of autophagosomes and induces motor neuron degeneration","volume":"8","author":"Ikenaka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0455","doi-asserted-by":"crossref","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","article-title":"TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity","volume":"284","author":"Johnson","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0465","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.20420","article-title":"Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity","volume":"57","author":"Jokic","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0460","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.embor.7400826","article-title":"The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model","volume":"7","author":"Jokic","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0470","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2013.04.012","article-title":"NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport","volume":"56","author":"Jouroukhin","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0475","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn.3357","article-title":"Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis","volume":"16","author":"Kang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0480","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0485","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.21743","article-title":"Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III","volume":"66","author":"Kaufmann","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0490","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","article-title":"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress","volume":"115","author":"Kawaguchi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0495","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.mad.2010.05.003","article-title":"Mitochondrial dysfunction and intracellular calcium dysregulation in ALS","volume":"131","author":"Kawamata","year":"2010","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0500","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.expneurol.2010.12.010","article-title":"Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice","volume":"228","author":"Keller","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0505","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1083\/jcb.200501085","article-title":"A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice","volume":"169","author":"Kieran","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0510","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","article-title":"Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord","volume":"29","author":"Kigerl","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0515","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.nbd.2013.07.011","article-title":"Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis","volume":"59","author":"Kim","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0520","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice","volume":"441","author":"Komatsu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0525","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1523\/JNEUROSCI.18-09-03241.1998","article-title":"Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1","volume":"18","author":"Kong","year":"1998","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0530","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/nbdi.2002.0487","article-title":"Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Kriz","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0535","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0540","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0545","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/nn.3230","article-title":"Divergent roles of ALS-linked proteins FUS\/TLS and TDP-43 intersect in processing long pre-mRNAs","volume":"15","author":"Lagier-Tourenne","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0550","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ng1211","article-title":"VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death","volume":"34","author":"Lambrechts","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0555","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(02)00696-7","article-title":"Disruption of dynein\/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration","volume":"34","author":"LaMonte","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0560","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3121","article-title":"Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0565","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature11314","article-title":"Oligodendroglia metabolically support axons and contribute to neurodegeneration","volume":"487","author":"Lee","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0570","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.celrep.2013.10.049","article-title":"Hexanucleotide repeats in ALS\/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic","volume":"5","author":"Lee","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0575","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(08)70006-1","article-title":"Minocycline for patients with ALS","volume":"7","author":"Leigh","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0590","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/hmg\/ddm193","article-title":"Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish","volume":"16","author":"Lemmens","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0585","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tins.2010.02.003","article-title":"RNA metabolism and the pathogenesis of motor neuron diseases","volume":"33","author":"Lemmens","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0580","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1093\/hmg\/ddt073","article-title":"Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke","volume":"22","author":"Lemmens","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0595","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.brainres.2007.09.034","article-title":"Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS","volume":"1185","author":"Lepore","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0605","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nn.2210","article-title":"Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease","volume":"11","author":"Lepore","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0600","doi-asserted-by":"crossref","first-page":"e25968","DOI":"10.1371\/journal.pone.0025968","article-title":"Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS","volume":"6","author":"Lepore","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0610","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/bioinformatics\/bts725","article-title":"The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs","volume":"29","author":"Levine","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0615","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4161\/auto.5524","article-title":"Altered macroautophagy in the spinal cord of SOD1 mutant mice","volume":"4","author":"Li","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0620","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.22217","article-title":"PGC-1alpha protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model","volume":"44","author":"Liang","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0625","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","article-title":"Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS","volume":"237","author":"Liao","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0630","first-page":"1131","article-title":"Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders","volume":"16","author":"Lillo","year":"2009","journal-title":"J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0635","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1523\/JNEUROSCI.22-12-04825.2002","article-title":"Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease","volume":"22","author":"Lino","year":"2002","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0640","doi-asserted-by":"crossref","first-page":"8791","DOI":"10.1523\/JNEUROSCI.5053-11.2012","article-title":"Targeting of monomer\/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis","volume":"32","author":"Liu","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0645","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","article-title":"Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease","volume":"10","author":"Lobsiger","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0650","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/WNL.59.7.1077","article-title":"The overlap of amyotrophic lateral sclerosis and frontotemporal dementia","volume":"59","author":"Lomen-Hoerth","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0655","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1523\/JNEUROSCI.1877-07.2007","article-title":"Mutant Cu\/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression","volume":"27","author":"Lu","year":"2007","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0660","first-page":"38","article-title":"Guidelines for preclinical animal research in ALS\/MND: a consensus meeting","volume":"11","author":"Ludolph","year":"2010","journal-title":"Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0665","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/glia.20604","article-title":"Adult glial precursor proliferation in mutant SOD1G93A mice","volume":"56","author":"Magnus","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0670","first-page":"568","article-title":"Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis","volume":"13","author":"Martin","year":"2010","journal-title":"IDrugs Investig. Drugs J."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0675","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/hmg\/ddr021","article-title":"TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1","volume":"20","author":"McDonald","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0680","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.bbadis.2013.03.012","article-title":"Rodent models of amyotrophic lateral sclerosis","volume":"1832","author":"McGoldrick","year":"2013","journal-title":"BBA Mol. Basis Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0685","first-page":"378","article-title":"Glatiramer acetate has no impact on disease progression in ALS at 40mg\/day: a double-blind, randomized, multicentre, placebo-controlled trial","volume":"10","author":"Meininger","year":"2009","journal-title":"Amyotroph. Lateral Scler.Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0690","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrn3380","article-title":"Axonal transport deficits and neurodegenerative diseases","volume":"14","author":"Millecamps","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0695","first-page":"CD001447","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","author":"Miller","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0700","first-page":"CD001447","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"3","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0705","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0710","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00401-013-1189-3","article-title":"Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins","volume":"126","author":"Mori","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0715","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","article-title":"The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS","volume":"339","author":"Mori","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0720","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2007.06.045","article-title":"Increased autophagy in transgenic mice with a G93A mutant SOD1 gene","volume":"1167","author":"Morimoto","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0725","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1212\/01.WNL.0000134608.83927.B1","article-title":"Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS","volume":"63","author":"Munch","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0730","doi-asserted-by":"crossref","first-page":"e55948","DOI":"10.1371\/journal.pone.0055948","article-title":"EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE)","volume":"8","author":"Munro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0735","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nn1876","article-title":"Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons","volume":"10","author":"Nagai","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0740","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jns.2005.04.011","article-title":"Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of amyotrophic lateral sclerosis","volume":"235","author":"Nagano","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0745","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0750","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0755","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00308929","article-title":"Axonal swellings in the corticospinal tracts in amyotrophic lateral sclerosis","volume":"80","author":"Okamoto","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0760","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0765","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3858\/emm.2009.41.7.054","article-title":"Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice","volume":"41","author":"Park","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0770","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1523\/JNEUROSCI.1119-12.2013","article-title":"Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis","volume":"33","author":"Parone","year":"2013","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0775","first-page":"CD005225","article-title":"Creatine for amyotrophic lateral sclerosis\/motor neuron disease","volume":"12","author":"Pastula","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0780","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/507423a","article-title":"Preclinical research: make mouse studies work","volume":"507","author":"Perrin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0790","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0785","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/brain\/aws339","article-title":"Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis","volume":"136","author":"Philips","year":"2013","journal-title":"Brain J Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0795","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1523\/JNEUROSCI.1092-08.2008","article-title":"Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration","volume":"28","author":"Poesen","year":"2008","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0800","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nn.2779","article-title":"Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43","volume":"14","author":"Polymenidou","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0805","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1523\/JNEUROSCI.21-10-03369.2001","article-title":"Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment","volume":"21","author":"Pramatarova","year":"2001","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0810","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1205","article-title":"Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model","volume":"11","author":"Ralph","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0815","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1207","article-title":"Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS","volume":"11","author":"Raoul","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0820","doi-asserted-by":"crossref","first-page":"9860","DOI":"10.1074\/jbc.C113.452532","article-title":"The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures","volume":"288","author":"Reddy","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0830","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0825","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0835","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","article-title":"Prevalence and patterns of cognitive impairment in sporadic ALS","volume":"65","author":"Ringholz","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00221-009-1742-4","article-title":"Retrogradely transported siRNA silences human mutant SOD1 in spinal cord motor neurons","volume":"195","author":"Rizvanov","year":"2009","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0845","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrn3430","article-title":"The changing scene of amyotrophic lateral sclerosis","volume":"14","author":"Robberecht","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0855","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410380114","article-title":"Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis","volume":"38","author":"Rothstein","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0850","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0860","doi-asserted-by":"crossref","first-page":"208ra149","DOI":"10.1126\/scitranslmed.3007529","article-title":"Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion","volume":"5","author":"Sareen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0865","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/nen.0b013e31802c396b","article-title":"Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis","volume":"66","author":"Sasaki","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0870","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0022-510X(92)90017-F","article-title":"Increase in diameter of the axonal initial segment is an early change in amyotrophic lateral sclerosis","volume":"110","author":"Sasaki","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0875","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nrn2936","article-title":"Functions of Nogo proteins and their receptors in the nervous system","volume":"11","author":"Schwab","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0880","first-page":"4","article-title":"Design, power, and interpretation of studies in the standard murine model of ALS","volume":"9","author":"Scott","year":"2008","journal-title":"Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0885","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/01.WNL.0000142992.81995.F0","article-title":"A clinical trial of creatine in ALS","volume":"63","author":"Shefner","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0890","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI25424","article-title":"Antisense oligonucleotide therapy for neurodegenerative disease","volume":"116","author":"Smith","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0895","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1326-8-31","article-title":"Rapamycin increases survival in ALS mice lacking mature lymphocytes","volume":"8","author":"Staats","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0900","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00702-012-0910-z","article-title":"The dynactin p150 subunit: cell biology studies of sequence changes found in ALS\/MND and Parkinsonian syndromes","volume":"120","author":"Stockmann","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0905","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nn1360","article-title":"Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS","volume":"8","author":"Storkebaum","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0910","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.neuropharm.2012.02.013","article-title":"Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model","volume":"62","author":"Sunyach","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0925","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tins.2008.01.006","article-title":"Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis","volume":"31","author":"Suzuki","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0920","doi-asserted-by":"crossref","first-page":"e689","DOI":"10.1371\/journal.pone.0000689","article-title":"GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS","volume":"2","author":"Suzuki","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0915","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/mt.2008.197","article-title":"Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS","volume":"16","author":"Suzuki","year":"2008","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0930","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/hmg\/ddt028","article-title":"Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS","volume":"22","author":"Taes","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0935","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0940","doi-asserted-by":"crossref","first-page":"11588","DOI":"10.1523\/JNEUROSCI.5385-12.2013","article-title":"Small peptides against the mutant SOD1\/Bcl-2 toxic mitochondrial complex restore mitochondrial function and cell viability in mutant SOD1-mediated ALS","volume":"33","author":"Tan","year":"2013","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0945","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/NEN.0b013e318275df4b","article-title":"Decreased mRNA expression of PGC-1alpha and PGC-1alpha-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS","volume":"71","author":"Thau","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0950","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4161\/auto.7.9.16012","article-title":"In vivo optical imaging of motor neuron autophagy in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Tian","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0955","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/hmg\/ddr448","article-title":"Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS\/TLS harbouring ALS-linked mutations","volume":"21","author":"Tradewell","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0960","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp.74.9.1258","article-title":"Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996\u20132000","volume":"74","author":"Traynor","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0965","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0970","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1073\/pnas.0606201104","article-title":"Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis","volume":"104","author":"Urushitani","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0980","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/WCO.0b013e32832ffbe3","article-title":"Recent advances in motor neuron disease","volume":"22","author":"Van Damme","year":"2009","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0975","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1073\/pnas.0705046104","article-title":"Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity","volume":"104","author":"Van Damme","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0990","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00001756-200206120-00018","article-title":"Minocycline delays disease onset and mortality in a transgenic model of ALS","volume":"13","author":"Van Den Bosch","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2014.07.001_bb0985","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2004.06.004","article-title":"Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration","volume":"17","author":"Van Den Bosch","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb0995","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/nm.2901","article-title":"EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans","volume":"18","author":"Van Hoecke","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1000","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.07.001_bb1010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1523\/JNEUROSCI.4433-06.2007","article-title":"Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice","volume":"27","author":"Wang","year":"2007","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1005","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1093\/hmg\/ddt319","article-title":"The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons","volume":"22","author":"Wang","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/4553","article-title":"Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons","volume":"2","author":"Williamson","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nn.2575","article-title":"Autophagy gone awry in neurodegenerative diseases","volume":"13","author":"Wong","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1025","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","article-title":"An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria","volume":"14","author":"Wong","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2014.07.001_bb1030","doi-asserted-by":"crossref","first-page":"10851","DOI":"10.1523\/JNEUROSCI.1630-10.2010","article-title":"Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice","volume":"30","author":"Xu","year":"2010","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2014.07.001_bb1040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1045","first-page":"1329","article-title":"[Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)]","volume":"36","author":"Yanagisawa","year":"1996","journal-title":"Rinsho Shinkeigaku Clin. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2011.06.003","article-title":"Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis","volume":"231","author":"Yoo","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1055","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1083\/jcb.139.5.1307","article-title":"Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation","volume":"139","author":"Zhang","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4161\/auto.7.4.14541","article-title":"Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Zhang","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2014.07.001_bb1070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nbd.2013.03.008","article-title":"Melatonin inhibits the caspase-1\/cytochrome c\/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"55","author":"Zhang","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1075","doi-asserted-by":"crossref","first-page":"e76055","DOI":"10.1371\/journal.pone.0076055","article-title":"Downregulation of microRNA-9 in iPSC-derived neurons of FTD\/ALS patients with TDP-43 mutations","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2014.07.001_bb1060","doi-asserted-by":"crossref","DOI":"10.4161\/auto.27710","article-title":"MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Zhang","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2014.07.001_bb1080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1326-6-51","article-title":"Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1alpha) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis","volume":"6","author":"Zhao","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1085","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbrc.2007.09.088","article-title":"VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice","volume":"363","author":"Zheng","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu","year":"2002","journal-title":"Nature"},{"issue":"Pt 15","key":"10.1016\/j.expneurol.2014.07.001_bb1095","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1242\/jcs.110.15.1741","article-title":"TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling","volume":"110","author":"Zinszner","year":"1997","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.expneurol.2014.07.001_bb1100","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1523\/JNEUROSCI.2978-04.2004","article-title":"Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice","volume":"24","author":"Zu","year":"2004","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614002295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614002295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T22:14:45Z","timestamp":1717020885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488614002295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":220,"alternative-id":["S0014488614002295"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.07.001","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS)","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.expneurol.2014.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}